Neuroendocrine/Carcinoid Clinical Trials

Showing 1-2 of 2 items
1.
  • Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
  • Cabozantinib works by blocking the growth of new blood vessels that feed a tumor. In addition to blocking the formation of new blood cells in tumors, cabozantinib also blocks pathways that may be responsible for allowing cancers cells to become resistant to other "anti-angiogenic" drugs. Cabozantinib has been studied or is being study in research studies as a possible treatment for various types of cancer, including prostate cancer, brain cancer, thyroid cancer, lung cancer, and kidney cancer. In this research study, the investigators wish to learn if cabozantinib is effective in treating patients with pancreatic neuroendocrine and carcinoid tumors.
  • Diagnoses: Gastrointestinal Malignancies, Neuroendocrine/Carcinoid
  • Status: Recruiting
2.
Showing 1-2 of 2 items
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms